Ingalls & Snyder’s CEL-SCI CVM Stock Holding History
Bought
Maintained
Sold
Other funds holding CVM
Ingalls & Snyder's CVM Position: Q2 2023 in Review
Ingalls & Snyder sold out of CEL-SCI (CVM) in Q2 2023, closing a stake of 337 shares — an estimated $23K sold.
Ingalls & Snyder first reported a position in CVM in Q4 2020 and held it in 10 quarters. The position peaked at $700K in Q3 2021. 60 funds tracked by Wall St. Rank hold CVM as of Q2 2023.
- Ingalls & Snyder reported no remaining CEL-SCI position as of Q2 2023 after selling out during the quarter.
- Ingalls & Snyder sold 337 CEL-SCI shares in Q2 2023, an estimated $23K.
- Ingalls & Snyder first reported a position in CEL-SCI in Q4 2020 and held it in 10 quarters.
- Ingalls & Snyder's CEL-SCI position peaked at $700K in Q3 2021.
- 60 funds tracked by Wall St. Rank held CEL-SCI as of Q2 2023.
Based on Ingalls & Snyder's 13F filing for Q2 2023, filed 27 Jul 2023.